{
    "title": "Lilly, Boehringer say Jardiance slows kidney disease progression in trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11390817/Lilly-Boehringer-say-Jardiance-slows-kidney-disease-progression-trial.html",
    "date": "2022-11-04",
    "keywords": [
        "kidney",
        "jardiance",
        "disease",
        "trial",
        "drug",
        "progression",
        "ckd",
        "boehringer",
        "risk",
        "death",
        "group",
        "year",
        "dapackd",
        "blood",
        "population",
        "frankfurt",
        "ingelheim",
        "market",
        "segment",
        "leader",
        "astrazeneca",
        "statement",
        "latestage",
        "march",
        "monitoring",
        "panel",
        "comparator",
        "patient",
        "placebo",
        "germany",
        "partner",
        "authorization",
        "approval",
        "product",
        "farxiga",
        "use",
        "increase",
        "pill",
        "study",
        "wider",
        "protein",
        "practice",
        "head",
        "medicine",
        "fall",
        "category",
        "sugar",
        "class",
        "heart",
        "failure",
        "onset",
        "loss",
        "function",
        "dialysis",
        "royalty",
        "condition",
        "control",
        "prevention",
        "burger",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}